Diabetes management has evolved significantly with the introduction of technologies that prioritize patient comfort and ease of use. A revolutionary product making waves in the industry is the Eversense E3 CGM (Continuous Glucose Monitor). As the only fully implantable CGM sensor on the market, and with a wear time of 180 days, this device represents a notable advancement in diabetes care.
Patients have shared that the insertion process for the Eversense E3 CGM is surprisingly straightforward. Typically performed by a specialist, the procedure takes less than 10 minutes and can be conducted in a relaxed setting. Using a small amount of numbing medication, such as lidocaine, the healthcare provider inserts the sensor under the skin of the arm with a specially designed tool. Once the sensor is in place, Steri-Strips are applied over the insertion site, and voilà - the procedure is complete! In six months, the sensor is replaced with a new one, usually in the same location on the other arm.
The Eversense E3 CGM has an array of innovative features designed for user-friendliness. It comes with double-sided adhesives in white and clear that securely hold the lightweight transmitter over the insertion site. The device also offers a dedicated mobile app compatible with Apple and Android devices. This app provides all the standard metrics of a CGM device, including glucose averages and standard deviation.
The transmitter itself is so light that patients often forget it's there. It sends glucose readings to the patient's smartphone every five minutes. Users remove the transmitter to charge it, typically once a day, during routine activities like showering or preparing a meal.
One of the standout features of the Eversense E3 CGM is its impressive accuracy. After calibrating with a finger stick measurement twice daily for the first three weeks, the device only requires a single daily calibration. With just a 5 to 10% difference from standard glucose meter readings, the accuracy of the E3 is reassuring for patients.
A unique feature of the Eversense E3 CGM is the silent, vibrating on-body alerts for high and low glucose levels. This feature allows users to manage their condition discreetly. The device is also water-resistant up to 1 meter for 30 minutes, providing freedom for activities like swimming.
However, it's essential to consider some limitations. For instance, if a patient requires an MRI, the transmitter must be removed for the procedure but can be promptly reattached afterward. Additionally, while the transmitter can remain on during TSA screenings for travel, it must be taken off for certain activities.
Overall, the Eversense E3 CGM represents a significant step forward in the field of diabetes management. Its design combines comfort, functionality, and accuracy, providing a novel solution for continuous glucose monitoring. As with all healthcare decisions, patients should discuss this option with their healthcare provider to determine if the Eversense E3 CGM is the right fit for their lifestyle and health needs.